GlobeNewswire by notified

AMG Schedule for First Quarter 2024 Earnings Release

Share

Amsterdam, 30 April 2024 --- AMG Critical Materials N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") will release its first quarter 2024 financial results on Tuesday, May 7, 2024, at approximately 18:00 CEST. AMG will host a conference call to discuss its financial results for the first quarter of 2024 at 09:00 CEST (08:00 BST / 3:00AM EDT) on Wednesday, May 8, 2024.

Please connect approximately 10 minutes prior to the beginning of the call to ensure participation. The call-in information is as follows:

Toll-free number: 1-888-632-3384

Alternate (toll) number: 1-785-424-1794

United Kingdom: 44 0800 048 7798

Netherlands: 31 0800 022 9530

When prompted for the conference ID, tell the operator AMGQ124 and you will be directed onto the call. The conference call will be available on the website www.amg-nv.com within twenty-four hours following completion of the call.

About AMG

AMG's mission is to provide critical materials and related process technologies to advance a less carbon-intensive world. To this end, AMG is focused on the production and development of energy storage materials such as lithium, vanadium, and tantalum. In addition, AMG's products include highly engineered systems to reduce CO2 in aerospace engines, as well as critical materials addressing CO2 reduction in a variety of other end use markets.

AMG’s Lithium segment spans the lithium value chain, reducing the CO2 footprint of both suppliers and customers. AMG’s Vanadium segment is the world’s market leader in recycling vanadium from oil refining residues, spanning the Company’s vanadium, titanium, and chrome businesses. AMG’s Technologies segment is the established world market leader in advanced metallurgy and provides equipment engineering to the aerospace engine sector globally. It serves as the engineering home for the Company’s fast-growing LIVA batteries, and spans AMG’s mineral processing operations in graphite, antimony, and silicon metal.

With approximately 3,600 employees, AMG operates globally with production facilities in Germany, the United Kingdom, France, the United States, China, Mexico, Brazil, India, Sri Lanka, and Mozambique, and has sales and customer service offices in Japan (www.amg-nv.com).

For further information, please contact:
AMG Critical Materials N.V.+1 610 975 4979
Michele Fischer
mfischer@amg-nv.com

Disclaimer

Certain statements in this press release are not historical facts and are “forward looking”. Forward looking statements include statements concerning AMG’s plans, expectations, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans and intentions relating to acquisitions, AMG’s competitive strengths and weaknesses, plans or goals relating to forecasted production, reserves, financial position and future operations and development, AMG’s business strategy and the trends AMG anticipates in the industries and the political and legal environment in which it operates and other information that is not historical information. When used in this press release, the words “expects,” “believes,” “anticipates,” “plans,” “may,” “will,” “should,” and similar expressions, and the negatives thereof, are intended to identify forward looking statements. By their very nature, forward looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that the predictions, forecasts, projections and other forward looking statements will not be achieved. These forward looking statements speak only as of the date of this press release. AMG expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statement contained herein to reflect any change in AMG's expectations with regard thereto or any change in events, conditions, or circumstances on which any forward looking statement is based.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

SalMar – Mandatory notification of trade21.5.2024 18:30:15 CEST | Press release

Eva Haugen primary insider and director quality management/HSE, has 21.05.2024 sold 7 900 shares in SalMar at a price of 665 NOK per share. After the transaction Eva Haugen owns 0 shares and 3,233 Restricted Share Units in SalMar. Please see attached document in accordance with the Market Abuse Regulation article 19. This notification has been submitted pursuant to the Securities Trading Act section 5-12. Attachment PDMR form - EHaugen

Repurchase of Shares21.5.2024 18:30:00 CEST | Press release

Repurchase of Shares Amsterdam, the Netherlands - Flow Traders Ltd. (Euronext: FLOW) has repurchased 75,900 of its own shares in the period from 13 May 2024 up to and including 17 May 2024 at an average price of €19.63. This is in accordance with the €15 million share buyback extension program originally announced on 27 October 2022, of which the period of execution was announced on 28 July 2023 to be extended by 12 months to 26 October 2024. The consideration of this purchase was €1.5 million. The total number of shares purchased under this program to date is 665,060 shares at an average price of €17.87 for a total consideration of €11.9 million. 2,427,442 shares were held in treasury as of 17 May 2024. Contact Details Flow Traders Ltd. Investors Eric Pan Phone: +31 20 7996180 Email: investor.relations@flowtraders.com About Flow Traders Flow Traders is a leading trading firm providing liquidity in multiple asset classes, covering all major exchanges. Founded in 2004, Flow Traders is a

Evs Communicates the Results of the Ordinary General Meeting21.5.2024 18:30:00 CEST | Press release

Publication on May 21, 2024, after market closure Regulated information EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS COMMUNICATES THE RESULTS OF THE ORDINARY GENERAL MEETING EVS Broadcast Equipment SA, leading provider of live video production systems, held its Ordinary General Meeting on May 21, 2024. In total 116 shareholders representing 3,860,045 shares, or 26.9% of the company shares, attended (by proxy and physically) the Ordinary General Meeting held physically at the company's registered office. All the resolutions have been approved, i.e.: - The remuneration report, the discharge of the Directors and the Auditor; - The 2023 annual accounts and the allocation of profits, including a total gross dividend of EUR 1.10 for fiscal year 2023 (such dividend is made up, on the one hand, of the interim dividend of EUR 0.50 gross per existing share, paid in November 2023 and, on the other hand, of a balance of EUR 0.60 gross per shar

ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication21.5.2024 18:25:00 CEST | Press release

Nature Medicine published Up-LIFT pivotal trial results Company will discuss pivotal trial results during webcast this week with company leaders and study principal investigators and participants EINDHOVEN, the Netherlands, May 21, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that on Thursday, May 23rd at 2:30pm CET/8:30am ET following a brief Q1 Business Update, CEO Dave Marver will host a discussion of Up-LIFT pivotal trial results with a panel of company leaders, study principal investigators, and study participants. The Up-LIFT trial demonstrated the safety and effectiveness of external ARC-EX Therapy to improve hand and arm function after spinal cord injury. Panelists will include Up-LIFT principal investigators Drs. Jim Guest, Chet Moritz, and Candace Tefertiller, trial parti

HiddenA line styled icon from Orion Icon Library.Eye